| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial
|
Schmitz, Renée S.J.M.
|
|
|
192 |
C |
p.
|
artikel
|
| 2 |
A forgotten dimension of big data in drug repositioning
|
Rassy, Elie
|
|
|
192 |
C |
p.
|
artikel
|
| 3 |
Association between local treatment modalities and event-free survival, overall survival, and local recurrence in patients with localised Ewing Sarcoma. Report from the Ewing 2008 trial
|
Heesen, Philip
|
|
|
192 |
C |
p.
|
artikel
|
| 4 |
Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: a nationwide, population-based study
|
Ben Khaled, Najib
|
|
|
192 |
C |
p.
|
artikel
|
| 5 |
Delayed and persistent multisystem toxicities of adjuvant anti-PD-1 therapy for stage III melanoma
|
Goodman, Rachel S.
|
|
|
192 |
C |
p.
|
artikel
|
| 6 |
Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial
|
Fizazi, Karim
|
|
|
192 |
C |
p.
|
artikel
|
| 7 |
Efficacy of PD-1 inhibitors for colorectal cancer and polyps in Lynch syndrome patients
|
Yu, Jie-Hai
|
|
|
192 |
C |
p.
|
artikel
|
| 8 |
Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years
|
Blay, JY
|
|
|
192 |
C |
p.
|
artikel
|
| 9 |
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023
|
Peris, Ketty
|
|
|
192 |
C |
p.
|
artikel
|
| 10 |
Health care and socioeconomic costs for long-term survivors after implementation of checkpoint-inhibitors and targeted agents for metastatic melanoma
|
Soerensen, Anne Vest
|
|
|
192 |
C |
p.
|
artikel
|
| 11 |
Letter re: Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients
|
Ding, Qian
|
|
|
192 |
C |
p.
|
artikel
|
| 12 |
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
|
Gelderblom, Hans
|
|
|
192 |
C |
p.
|
artikel
|
| 13 |
Pooled Safety Analysis of Single-Agent Lurbinectedin in Patients With Advanced Solid Tumours
|
Leary, Alexandra
|
|
|
192 |
C |
p.
|
artikel
|
| 14 |
Pseudoprogression in patients with uterine leiomyosarcoma treated with first-line single-agent doxorubicin
|
Howroyd, Lucy-Rose
|
|
|
192 |
C |
p.
|
artikel
|
| 15 |
Response to Letter Entitled “Re: Anthropometric indicators of adiposity and risk of primary liver cancer: a systematic review and dose-response meta-analysis”
|
Yan, Lun-Jie
|
|
|
192 |
C |
p.
|
artikel
|
| 16 |
Response to letter entitled: Re: Anthropometric indicators of adiposity and risk of primary liver cancer: a systematic review and dose-response meta-analysis
|
Zhao, Gang
|
|
|
192 |
C |
p.
|
artikel
|
| 17 |
Response to letter entitled Re: Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients
|
Persano, Mara
|
|
|
192 |
C |
p.
|
artikel
|
| 18 |
Secondary hypertrophic osteoarthropathy revealing a metastatic melanoma
|
Laillet, J.
|
|
|
192 |
C |
p.
|
artikel
|
| 19 |
Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases
|
Dohm, Ammoren E.
|
|
|
192 |
C |
p.
|
artikel
|
| 20 |
The association of excessive soft drinks consumption with early-onset colorectal cancer
|
Rehman, Obaid Ur
|
|
|
192 |
C |
p.
|
artikel
|
| 21 |
The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer
|
Agarwal, Neeraj
|
|
|
192 |
C |
p.
|
artikel
|
| 22 |
Trends and variation in treatment of early breast cancer in European certified breast centres: an EUSOMA-based analysis
|
van Walle, Lien
|
|
|
192 |
C |
p.
|
artikel
|
Tijdschrift beschrijving